Page last updated: 2024-08-26

mizoribine and Cytomegalovirus Infections

mizoribine has been researched along with Cytomegalovirus Infections in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (9.09)18.2507
2000's1 (9.09)29.6817
2010's8 (72.73)24.3611
2020's1 (9.09)2.80

Authors

AuthorsStudies
Chen, J; Chen, Z; Liu, H; Xu, Z; Yin, W; Yiu, W1
Akioka, K; Akutsu, N; Harada, S; Nakamura, T; Nakatani, T; Ushigome, H; Yoshimura, N1
Hasegawa, J; Hatakeyama, S; Mieno, M; Okumi, M; Omoto, K; Shirakawa, H; Tanabe, K; Wakai, S1
Hayashi, R; Hiromasa, T; Inoue, T; Kagawa, H; Sada, KE; Tsunashima, Y; Yamanaka, R1
Akioka, K; Fujisawa, M; Fukuda, Y; Horimi, T; Ito, SI; Nakatani, T; Nishimura, K; Sugitani, A; Uchida, K; Ushigome, H; Yoshimura, N; Yuzawa, K1
Matsuyama, M; Nobori, S; Okajima, H; Okamoto, M; Sakai, K; Suzuki, T; Ushigome, H; Yoshimura, N1
Akioka, K; Fujisawa, M; Fukuda, Y; Horimi, T; Ichikawa, Y; Ito, S; Nakatani, T; Nishimura, K; Sugitani, A; Uchida, K; Yoshimura, N; Yuzawa, K1
Abe, Y; Irie, S; Matsuoka, H; Mikami, H; Nakamura, N; Ogawara, S; Saitoh, T; Sasatomi, Y; Tanaka, M1
Akioka, K; Nobori, S; Okamoto, M; Sakai, K; Suzuki, T; Ushigome, H; Yoshimura, N1
Tanabe, K1
Emoto, Y; Maeda, K; Miyazaki, T; Naoe, T; Niwa, T; Yazawa, T1

Reviews

1 review(s) available for mizoribine and Cytomegalovirus Infections

ArticleYear
The Efficacy and Safety of Mizoribine versus Mycophenolate Mofetil for the Treatment of Renal Transplantation: A Systematic Review and Meta-Analysis.
    Computational intelligence and neuroscience, 2022, Volume: 2022

    Topics: Cytomegalovirus Infections; Gastrointestinal Diseases; Humans; Hyperuricemia; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Ribonucleosides

2022

Trials

1 trial(s) available for mizoribine and Cytomegalovirus Infections

ArticleYear
Beneficial Effects of High-Dose Mizoribine on ABO-Incompatible Living-Related Kidney Transplantation: Two-Year Results by a Japanese Multicenter Study.
    Transplantation proceedings, 2017, Volume: 49, Issue:5

    Topics: Adrenal Cortex Hormones; Adult; Blood Group Incompatibility; Cytomegalovirus Infections; Female; Humans; Immunosuppressive Agents; Japan; Kidney Transplantation; Male; Middle Aged; Ribonucleosides

2017

Other Studies

9 other study(ies) available for mizoribine and Cytomegalovirus Infections

ArticleYear
Preemptive anti-cytomegalovirus therapy in high-risk (donor-positive, recipient-negative cytomegalovirus serostatus) kidney transplant recipients.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2017, Volume: 65

    Topics: Adult; Antibodies, Monoclonal; Antiviral Agents; Basiliximab; Cytomegalovirus; Cytomegalovirus Infections; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kaplan-Meier Estimate; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Recombinant Fusion Proteins; Retrospective Studies; Ribonucleosides; Risk Factors; Rituximab; Tacrolimus; Tissue Donors; Treatment Outcome

2017
The first year results of mizoribine/tacrolimus-based multitarget treatment for consecutive patients with lupus nephritis.
    Clinical and experimental nephrology, 2018, Volume: 22, Issue:6

    Topics: Adolescent; Adult; Aged; Cytomegalovirus Infections; Female; Humans; Lupus Nephritis; Male; Middle Aged; Ribonucleosides; Tacrolimus; Young Adult

2018
Efficacy and Safety of High-Dose Mizoribine Combined With Cyclosporine, Basiliximab, and Corticosteroids in Renal Transplantation: A Japanese Multicenter Study.
    Transplantation proceedings, 2016, Volume: 48, Issue:3

    Topics: Adult; Aged; Anemia; Antibodies, Monoclonal; Basiliximab; Case-Control Studies; Cyclosporine; Cytomegalovirus Infections; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Glucocorticoids; Humans; Immunosuppressive Agents; Japan; Kidney Transplantation; Leukopenia; Male; Middle Aged; Mycophenolic Acid; Opportunistic Infections; Prednisolone; Recombinant Fusion Proteins; Ribonucleosides; Viremia; Young Adult

2016
The efficacy and safety of high-dose mizoribine in ABO-incompatible kidney transplantation using anti-CD20 and anti-CD25 antibody without splenectomy treatment.
    Transplantation proceedings, 2012, Volume: 44, Issue:1

    Topics: ABO Blood-Group System; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antiviral Agents; Basiliximab; Biomarkers; Blood Group Incompatibility; Creatinine; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Histocompatibility; Humans; Immunosuppressive Agents; Interleukin-2 Receptor alpha Subunit; Japan; Kaplan-Meier Estimate; Kidney Transplantation; Living Donors; Male; Middle Aged; Recombinant Fusion Proteins; Ribonucleosides; Rituximab; Splenectomy; Time Factors; Treatment Outcome; Young Adult

2012
Excellent results with high-dose mizoribine combined with cyclosporine, corticosteroid, and basiliximab in renal transplant recipients: multicenter study in Japan.
    Transplantation proceedings, 2012, Volume: 44, Issue:1

    Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antiviral Agents; Basiliximab; Biomarkers; BK Virus; Creatinine; Cyclosporine; Cytomegalovirus Infections; Drug Monitoring; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Japan; Kidney Transplantation; Male; Middle Aged; Polyomavirus Infections; Recombinant Fusion Proteins; Ribonucleosides; Treatment Outcome

2012
Experiences of high-dose mizoribine as antimetabolite immunosuppressants for kidney transplantation.
    Transplantation proceedings, 2012, Volume: 44, Issue:1

    Topics: Adolescent; Adult; BK Virus; Child; Cytomegalovirus Infections; Female; Graft Rejection; Graft Survival; Herpes Zoster; Humans; Immunosuppressive Agents; Japan; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Polyomavirus Infections; Retrospective Studies; Ribonucleosides; Treatment Outcome; Young Adult

2012
The beneficial effect of high-dose mizoribine combined with cyclosporine, basiliximab, and corticosteroids on CMV infection in renal transplant recipients.
    Clinical and experimental nephrology, 2013, Volume: 17, Issue:1

    Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antiviral Agents; Basiliximab; Biomarkers; Creatinine; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Ganciclovir; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Kidney Transplantation; Living Donors; Male; Middle Aged; Recombinant Fusion Proteins; Ribonucleosides; Treatment Outcome; Young Adult

2013
Japanese experience of ABO-incompatible living kidney transplantation.
    Transplantation, 2007, Dec-27, Volume: 84, Issue:12 Suppl

    Topics: ABO Blood-Group System; Antigens, CD20; Azathioprine; Blood Group Incompatibility; Cytomegalovirus Infections; Histocompatibility Testing; Humans; Immunosuppressive Agents; Japan; Kidney Transplantation; Plasmapheresis; Ribonucleosides; Time Factors; Treatment Outcome

2007
A case of lupus nephritis showing rectal erosion with cytomegalovirus infection.
    Nihon Jinzo Gakkai shi, 1991, Volume: 33, Issue:5

    Topics: Adult; Cytomegalovirus Infections; Female; Humans; Lupus Nephritis; Prednisolone; Rectal Diseases; Ribonucleosides

1991